Carbohydrate digestibility and metabolic effects

Journal of Nutrition

Volumn 137, Issue 11, 2007, Pages

  Wong, Julia M W ^a,b   Jenkins, David J A ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AGLYCONE; BUTYRIC ACID; CARBOHYDRATE; GLUCONIC ACID; GLUCOSE; INSULIN; PHENOL DERIVATIVE; PROPIONIC ACID; SHORT CHAIN FATTY ACID;

BIFIDOBACTERIUM; BIOTRANSFORMATION; CARBOHYDRATE ABSORPTION; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; COLON; COLON FLORA; CONCEPT ANALYSIS; CONFERENCE PAPER; DIABETES MELLITUS; DIGESTION; DOCUMENTATION; FERMENTATION; FOOD; GLYCEMIC INDEX; HEALTH; HOST; HUMAN; ISCHEMIC HEART DISEASE; MALABSORPTION; MORBIDITY; PLANT; POPULATION; SMALL INTESTINE; STIMULATION;

EID: 35848954727     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.11.2539s     Document Type: Conference Paper

References (132)

1. Preventing chronic diseases: a vital investment: WHO global report. Geneva: World Health Organization; 2005.
2. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84.
3. Roberfroid MB. Introducing inulin-type fructans. Br J Nutr. 2005;93: Suppl 1:S13-25.
4. Cummings JH, Branch WJ. Fermentation and the production of short chain fatty acids in the human large intestine. In: Vahonny GV, Kritchevsky D, editors. Dietary fiber: basic and clinical aspects. New York: Plenum Press; 1986. p. 131-149.
5. Wolever TM, Cohen Z, Thompson LU, Thorne MJ, Jenkins MJ, Prokipchuk EJ, Jenkins DJ. Ileal loss of available carbohydrate in man: comparison of a breath hydrogen method with direct measurement using a human ileostomy model. Am J Gastroenterol. 1986;81:115-22.
6. Jenkins DJ, Cuff D, Wolever TM, Knowland D, Thompson L, Cohen Z, Prokipchuk E. Digestibility of carbohydrate foods in an ileostomate: relationship to dietary fiber, in vitro digestibility, and glycemic response. Am J Gastroenterol. 1987;82:709-17.
7. Anderson IH, Levine AS, Levitt MD. Incomplete absorption of the carbohydrate in all-purpose wheat flour. N Engl J Med. 1981;304:891-2.
8. Englyst HN, Cummings JH. Digestion of the carbohydrates of banana (Musa paradisiaca sapientum) in the human small intestine. Am J Clin Nutr. 1986;44:42-50.
9. Steinhart AH, Jenkins DJ, Mitchell S, Cuff D, Prokipchuk EJ. Effect of dietary fiber on total carbohydrate losses in ileostomy effluent. Am J Gastroenterol. 1992;87:48-54.
10. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34:362-6.
11. Englyst KN, Englyst HN, Hudson GJ, Cole TJ, Cummings JH. Rapidly available glucose in foods: an in vitro measurement that reflects the glycemic response. Am J Clin Nutr. 1999;69:448-54.
12. Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, Pi-Sunyer FX, Mayer-Davis E, Kulkarni K, Geil P. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association. Diabetes Care. 2004;27:2266-71.
13. Haber GB, Heaton KW, Murphy D, Burroughs LF. Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet. 1977;2:679-82.
14. O'Dea K, Nestel PJ, Antonoff L. Physical factors influencing postprandial glucose and insulin responses to starch. Am J Clin Nutr. 1980;33:760-5.
15. Jenkins DJ, Thorne MJ, Camelon K, Jenkins A, Rao AV, Taylor RH, Thompson LU, Kalmusky J, Reichert R, Francis T. Effect of processing on digestibility and the blood glucose response: a study of lentils. Am J Clin Nutr. 1982;36:1093-101.
16. Wursch P, Del Vedovo S, Koellreutter B. Cell structure and starch nature as key determinants of the digestion rate of starch in legume. Am J Clin Nutr. 1986;43:25-9.
17. Isaksson G, Lundquist I, Ihse I. Effect of dietary fiber on pancreatic enzyme activity in vitro. Gastroenterology. 1982;82:918-24.
18. Yoon JH, Thompson LU, Jenkins DJ. The effect of phytic acid on in vitro rate of starch digestibility and blood glucose response. Am J Clin Nutr. 1983;38:835-42.
19. Englyst HN, Kingman SM, Cummings JH. Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr. 1992;46: Suppl 2:S33-50.
20. Krezowski PA, Nuttall FQ, Gannon MC, Bartosh NH. The effect of protein ingestion on the metabolic response to oral glucose in normal individuals. Am J Clin Nutr. 1986;44:847-56.
21. Thorne MJ, Thompson LU, Jenkins DJ. Factors affecting starch digestibility and the glycemic response with special reference to legumes. Am J Clin Nutr. 1983;38:481-8.
22. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-12.
23. Macfarlane S, Macfarlane GT, Cummings JH. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther. 2006;24:701-14.
24. Andersson HB, Ellegard LH, Bosaeus IG. Nondigestibility characteristics of inulin and oligofructose in humans. J Nutr. 1999;129:1428S-30S.
25. Ellegard L, Andersson H, Bosaeus I. Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects. Eur J Clin Nutr. 1997;51:1-5.
26. Burkitt DP, Trowell HC. Dietary fibre and Western diseases. Ir Med J. 1977;70:272-7.
27. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, Jenkins AL, Axelsen M. Glycemic index: overview of implications in health and disease. Am J Clin Nutr. 2002;76:266S-73S.
28. Jenkins DJ, Wolever TM, Ocana AM, Vuksan V, Cunnane SC, Jenkins M, Wong GS, Singer W, Bloom SR, et al. Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping. Diabetes. 1990;39:775-81.
29. Jenkins DJ, Ocana A, Jenkins AL, Wolever TM, Vuksan V, Katzman L, Hollands M, Greenberg G, Corey P, et al. Metabolic advantages of spreading the nutrient load: effects of increased meal frequency in non-insulin-dependent diabetes. Am J Clin Nutr. 1992;55:461-7.
30. Bertelsen J, Christiansen C, Thomsen C, Poulsen PL, Vestergaard S, Steinov A, Rasmussen LH, Rasmussen O, Hermansen K. Effect of meal frequency on blood glucose, insulin, and free fatty acids in NIDDM subjects. Diabetes Care. 1993;16:4-7.
31. Jones PJ, Leitch CA, Pederson RA. Meal-frequency effects on plasma hormone concentrations and cholesterol synthesis in humans. Am J Clin Nutr. 1993;57:868-74.
32. Jenkins DJ, Wolever TM, Vuksan V, Brighenti F, Cunnane SC, Rao AV, Jenkins AL, Buckley G, Patten R, et al. Nibbling versus gorging: metabolic advantages of increased meal frequency. N Engl J Med. 1989;321:929-34.
33. Jenkins DJ, Khan A, Jenkins AL, Illingworth R, Pappu AS, Wolever TM, Vuksan V, Buckley G, Rao AV, et al. Effect of nibbling versus gorging on cardiovascular risk factors: serum uric acid and blood lipids. Metabolism. 1995;44:549-55.
34. Arnold LM, Ball MJ, Duncan AW, Mann J. Effect of isoenergetic intake of three or nine meals on plasma lipoproteins and glucose metabolism. Am J Clin Nutr. 1993;57:446-51.
35. Cohn C. Feeding patterns and some aspects of cholesterol metabolism. Fed Proc. 1964;23:76-81.
36. Jenkins DJ, Jenkins AL. Nutrition principles and diabetes. A role for "lente carbohydrate"? Diabetes Care. 1995;18:1491-8.
37. Jenkins DJ, Wolever TM, Jenkins AL, Josse RG, Wong GS. The glycaemic response to carbohydrate foods. Lancet. 1984;2:388-91.
38. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76:5-56.
39. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997;20:545-50.
40. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for energy, carbohydrates, fiber, protein and amino acids (macronutrients). Washington, DC: National Academy Press; 2002.
41. Ford ES, Liu S. Glycemic index and serum high-density lipoprotein cholesterol concentration among us adults. Arch Intern Med. 2001;161:572-6.
42. Frost G, Leeds AA, Dore CJ, Madeiros S, Brading S, Dornhorst A. Glycaemic index as a determinant of serum HDL-cholesterol concentration. Lancet. 1999;353:1045-8.
43. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002;75:492-8.
44. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J. 2004;148:S19-26.
45. Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IE, Asp NG, Vessby BO. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care. 1999;22:10-8.
46. Jenkins DJ, Wolever TM, Kalmusky J, Guidici S, Giordano C, Patten R, Wong GS, Bird JN, Hall M, et al. Low-glycemic index diet in hyperlipidemia: use of traditional starchy foods. Am J Clin Nutr. 1987;46:66-71.
47. Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004;292:2482-90.
48. Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, Hennekens CH, Manson JE. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr. 2000;71:1455-61.
49. van Dam RM, Visscher AW, Feskens EJ, Verhoef P, Kromhout D. Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study. Eur J Clin Nutr. 2000;54:726-31.
50. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 2003;26:2261-7.
51. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12.
52. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997;277:472-7.
53. Meyer KA, Kushi LH, Jacobs DR, Jr., Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000;71:921-30.
54. Slattery ML, Benson J, Berry TD, Duncan D, Edwards SL, Caan BJ, Potter JD. Dietary sugar and colon cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:677-85.
55. Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M, Boyle P, Jenkins DJ, La Vecchia C. Dietary glycemic load and colorectal cancer risk. Ann Oncol. 2001;12:173-8.
56. Augustin LS, Dal Maso L, La Vecchia C, Parpinel M, Negri E, Vaccarella S, Kendall CW, Jenkins DJ, Francesch S. Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol. 2001;12:1533-8.
57. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3:687-95.
58. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6:164-79.
59. Boyd DB. Insulin and cancer. Integr Cancer Ther. 2003;2:315-29.
60. Wolever TM, Jenkins DJ, Ocana AM, Rao VA, Collier GR. Second-meal effect: low-glycemic-index foods eaten at dinner improve subsequent breakfast glycemic response. Am J Clin Nutr. 1988;48:1041-7.
61. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB. High glycemic index foods, overeating, and obesity. Pediatrics. 1999;103:E26.
62. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031-64.
63. Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763-79.
64. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21:793-8.
65. Jenkins DJ, Kendall CW, Vuksan V. Inulin, oligofructose and intestinal function. J Nutr. 1999;129:1431S-3S.
66. Floch MH, Hong-Curtiss J. Probiotics and functional foods in gastrointestinal disorders. Curr Treat Options Gastroenterol. 2002;5:311-21.
67. Roberfroid MB. Inulin-type fructans: functional food ingredients. Boca Raton, FL: CRC Press; 2005.
68. Vince A, Killingley M, Wrong OM. Effect of lactulose on ammonia production in a fecal incubation system. Gastroenterology. 1978;74:544-9.
69. Jackson AA. Aminoacids: essential and non-essential? Lancet. 1983;1:1034-7.
70. Jenkins DJ, Wolever TM, Collier GR, Ocana A, Rao AV, Buckley G, Lam Y, Mayer A, Thompson LU. Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr. 1987;46:968-75.
71. Stephen AM, Haddad AC, Phillips SF. Passage of carbohydrate into the colon. Direct measurements in humans. Gastroenterology. 1983;85:589-95.
72. Englyst HN, Cummings JH. Non-starch polysaccharides (dietary fiber) and resistant starch. Adv Exp Med Biol. 1990;270:205-25.
73. Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998;12:499-507.
74. Argenzio RA, Southworth M, Stevens CE. Sites of organic acid production and absorption in the equine gastrointestinal tract. Am J Physiol. 1974;226:1043-50.
75. Owens FN, Isaacson HR. Ruminal microbial yields: factors influencing synthesis and bypass. Fed Proc. 1977;36:198-202.
76. Cummings JH, Hill MJ, Bone ES, Branch WJ, Jenkins DJ. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr. 1979;32:2094-101.
77. McNeil NI, Cummings JH, James WP. Short chain fatty acid absorption by the human large intestine. Gut. 1978;19:819-22.
78. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG, Jr. Absorption of short-chain fatty acids by the colon. Gastroenterology. 1980;78:1500-7.
79. Roediger WE, Moore A. Effect of short-chain fatty acid on sodium absorption in isolated human colon perfused through the vascular bed. Dig Dis Sci. 1981;26:100-6.
80. Wolever TM, Brighenti F, Royall D, Jenkins AL, Jenkins DJ. Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol. 1989;84:1027-33.
81. Wolever TM, Spadafora P, Eshuis H. Interaction between colonic acetate and propionate in humans. Am J Clin Nutr. 1991;53:681-7.
82. Todesco T, Rao AV, Bosello O, Jenkins DJ. Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. Am J Clin Nutr. 1991;54:860-5.
83. Venter CS, Vorster HH, Cummings JH. Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol. 1990;85:549-53.
84. Amaral L, Hoppel C, Stephen AM. Effect of propionate on lipid metabolism in healthy human subjects. Falk Symposium 1993;73:E2.
85. Bush RS, Milligan LP. Study of the mechanism of inhibition of ketogenesis by propionate in bovine liver. Can J Anim Sci. 1971;51:121-7.
86. Rodwell VW, Nordstrom JL, Mitschelen JJ. Regulation of HMGCoA reductase. Adv Lipid Res. 1976;14:1-74.
87. Chen WJ, Anderson JW, Jennings D. Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats. Proc Soc Exp Biol Med. 1984;175:215-8.
88. Hara H, Haga S, Kasai T, Kiriyama S. Fermentation products of sugar-beet fiber by cecal bacteria lower plasma cholesterol concentration in rats. J Nutr. 1998;128:688-93.
89. Wright RS, Anderson JW, Bridges SR. Propionate inhibits hepatocyte lipid synthesis. Proc Soc Exp Biol Med. 1990;195:26-9.
90. Nishina PM, Freedland RA. Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J Nutr. 1990;120:668-73.
91. Hara H, Haga S, Aoyama Y, Kiriyama S. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr. 1999;129:942-8.
92. Thacker PA, Salamons MO, Aherne FX, Milligan LP, Bowland JP. Influence of propionic acid on the cholesterol metabolism of pigs fed hypercholesterolemic diets. Can J Anim Sci. 1981;61:969-975.
93. Illman RJ, Topping DL. Effects of dietary oat bran on faecel steroid excretion, plasma volatile fatty acids and lipid synthesis in rats. Nutr Res. 1985;5:839-46.
94. Ahrens F, Hagemeister H, Pfeuffer M, Barth CA. Effects of oral and intracecal pectin administration on blood lipids in minipigs. J Nutr. 1986;116:70-6.
95. Illman RJ, Topping DL, McIntosh GH, Trimble RP, Storer GB, Taylor MN, Cheng BQ. Hypocholesterolaemic effects of dietary propionate: studies in whole animals and perfused rat liver. Ann Nutr Metab. 1988;32:95-107.
96. Davidson MH, Maki KC, Synecki C, Torri SA, Drennan KB. Effects of dietary inulin in serum lipids in men and women with hypercholesterolemia. Nutr Res. 1998;18:503-17.
97. Jenkins DJ, Vuksan V, Kendall CW, Wursch P, Jeffcoat R, Waring S, Mehling CC, Vidgen E, Augustin LS, Wong E. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr. 1998;17:609-16.
98. van Munster IP, Tangerman A, Nagengast FM. Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig Dis Sci. 1994;39:834-42.
99. Noakes M, Clifton PM, Nestel PJ, Le Leu R, McIntosh G. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am J Clin Nutr. 1996;64:944-51.
100. Phillips J, Muir JG, Birkett A, Lu ZX, Jones GP, O'Dea K, Young GP. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. Am J Clin Nutr. 1995;62:121-30.
101. Englyst HN, Hay S, Macfarlane GT. Polysaccharide breakdown by mixed populations of human fecal bacteria. FEMS Microbiol Lett. 1987;45:163-71.
102. Vogt JA, Pencharz PB, Wolever TM. L-Rhamnose increases serum propionate in humans. Am J Clin Nutr. 2004;80:89-94.
103. Vogt JA, Ishii-Schrade KB, Pencharz PB, Jones PJ, Wolever TM. L-Rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. J Nutr. 2006;136:2160-6.
104. Jenkins DJ, Wolever TM, Jenkins A, Brighenti F, Vuksan V, Rao AV, Cunnane SC, Ocana A, Corey P, et al. Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. Am J Clin Nutr. 1991;54:141-7.
105. Luo J, Rizkalla SW, Alamowitch C, Boussairi A, Blayo A, Barry JL, Laffitte A, Guyon F, Bornet FR, Slama G. Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr. 1996;63:939-45.
106. Jenkins DJ, Hunter WM, Goff DV. Ketone bodies and evidence for increased insulin secretion. Nature. 1970;227:384-5.
107. Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982;83:424-9.
108. Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care. 2004;7:563-7.
109. Lupton JR. Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr. 2004;134:479-82.
110. Bornet FR, Brouns F, Tashiro Y, Duvillier V. Nutritional aspects of short-chain fructooligosaccharides: natural occurrence, chemistry, physiology and health implications. Dig Liver Dis. 2002;34: Suppl 2:S111-120.
111. Perrin P, Cassagnau E, Burg C, Patry Y, Vavasseur F, Harb J, Le Pendu J, Douillard JY, Galmiche JP, et al. An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology. 1994;107:1697-708.
112. Hague A, Elder DJ, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer. 1995;60:400-6.
113. Scheppach W, Bartram HP, Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer. 1995;31A:1077-80.
114. Archer SY, Meng S, Shei A, Hodin RA. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA. 1998;95:6791-6.
115. Siavoshian S, Segain JP, Kornprobst M, Bonnet C, Cherbut C, Galmiche JP, Blottiere HM. Butyrate and trichostatin A effects on the proliferation/ differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut. 2000;46:507-14.
116. Chai F, Evdokiou A, Young GP, Zalewski PD. Involvement of p21(Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. Carcinogenesis. 2000;21:7-14.
117. Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell. 1978;14:115-21.
118. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997;389:349-52.
119. Young GP, Hu Y, Le Leu RK, Nyskohus L. Dietary fibre and colorectal cancer: a model for environment-gene interactions. Mol Nutr Food Res. 2005;49:571-84.
120. Grubben MJ, van den Braak CC, Essenberg M, Olthof M, Tangerman A, Katan MB, Nagengast FM. Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial. Dig Dis Sci. 2001;46:750-6.
121. Thornton JR. High colonic pH promotes colorectal cancer. Lancet. 1981;1:1081-3.
122. Wargovich MJ, Eng VW, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984;23:253-8.
123. Roediger WE. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet. 1980;2:712-5.
124. Roedinger WE. The starved colon-diminished mucosal nutrition, diminished absorption, and colitis. Dis Colon Rectum. 1990;33:858-62.
125. Scheppach W, Christl SU, Bartram HP, Richter F, Kasper H. Effects of short-chain fatty acids on the inflamed colonic mucosa. Scand J Gastroenterol Suppl. 1997;222:53-7.
126. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989;320:23-8.
127. Guillemot F, Colombel JF, Neut C, Verplanck N, Lecomte M, Romond C, Paris JC, Cortot A. Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum. 1991;34:861-4.
128. Cummings JH. Short-chain fatty acid enemas in the treatment of distal ulcerative colitis. Eur J Gastroenterol Hepatol. 1997;9:149-53.
129. Breuer RI, Buto SK, Christ ML, Bean J, Vernia P, Paoluzi P, Di Paolo MC, Caprilli R. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci. 1991;36:185-7.
130. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992;103:51-6.
131. Breuer RI, Soergel KH, Lashner BA, Christ ML, Hanauer SB, Vanagunas A, Harig JM, Keshavarzian A, Robinson M, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut. 1997;40:485-91.
132. Steinhart AH, Hiruki T, Brzezinski A, Baker JP. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther. 1996;10:729-36.